| Aspect | Details | Evidence/notes | Key recent sources (with year) |
|---|---|---|---|
| Verified identity | **STAU2** matches the requested target: human **Staufen homolog 2**, a **double-stranded RNA-binding protein**; distinct from paralog **STAU1**. Recent reviews explicitly discuss human/mammalian STAU2 in the context of dsRNA-binding proteins and Staufen-mediated mRNA decay. | Identity is consistent with UniProt Q9NUL3 description and with recent literature describing STAU2 as one of two mammalian Staufen paralogs and a dsRBP. | Cottrell et al., *Molecular Cell* (2024) (pqac-00000010); Ciccopiedi (2024) (pqac-00000008) |
| Domains | STAU2 contains **multiple dsRNA-binding domains (dsRBDs)**; recent review imagery shows human STAU2 domain architecture with multiple dsRBDs. Thesis/review literature further notes mammalian Staufen proteins contain **4–5 dsRBDs** and a **tubulin-binding domain (TBD)**, with STAU2 being the paralog most similar to Drosophila Staufen. | Domain organization aligns with the UniProt-provided dsRBD/DRBM annotations. One 2024 source notes human STAU2 may have a degenerated RBD5 in some descriptions, so exact domain-function assignment should be treated cautiously unless directly confirmed for a given isoform. | Cottrell et al., *Molecular Cell* (2024) (pqac-00000010); Gaber thesis (2024) (pqac-00000005) |
| Core molecular function | STAU2 is an **RNA-binding post-transcriptional regulator** that recognizes **double-stranded/structured RNA elements**, especially **3′-UTR secondary structures/hairpins**, and functions in **mRNA transport/localization**, **translation control**, **mRNA stability**, and **Staufen-mediated mRNA decay (SMD)**. | Multiple recent reviews converge on STAU2 as a structured-RNA-binding factor acting in neuronal RNA localization and SMD rather than as an enzyme or transporter. | Zhukova et al., *BioEssays* (2024) (pqac-00000002, pqac-00000007); Ciccopiedi (2024) (pqac-00000008); Cottrell et al., *Molecular Cell* (2024) (pqac-00000010) |
| Subcellular localization | STAU2 is enriched in **brain and gonads** and in neurons localizes as **RNP particles** in the **soma and dendrites**; STAU2-containing RNPs traffic into dendrites along **microtubules**. Some literature also notes **isoform-specific nucleolar accumulation** and **exportin-5-dependent export**. | Evidence is strongest for neuronal cytoplasmic/dendritic localization and RNP granule behavior; additional nucleolar/export observations appear isoform-specific. | Ciccopiedi (2024) (pqac-00000008, pqac-00000009); Quesada (2023) (pqac-00000003) |
| Key mechanism: mRNA transport / local translation | STAU2-containing RNPs **traffic bidirectionally along microtubules** to deliver transcripts to dendrites, where transported mRNAs can undergo **compartmentalized/local translation**. Dominant-negative STAU2 perturbs this partitioning by reducing many dendritic RNAs and increasing somatic levels. | This supports a direct role in **subcellular mRNA localization** and local proteome control important for dendritic spine morphogenesis, synaptic plasticity, and memory-related neuronal functions. | Ciccopiedi (2024) (pqac-00000008, pqac-00000009); Zhukova et al., *BioEssays* (2024) (pqac-00000007) |
| Key mechanism: RNA target recognition | STAU2 binds **complex long-range RNA hairpins** and other **secondary structures in 3′ UTRs**. A highlighted example is **Calm3 mRNA**, where a **retained intron in the 3′ UTR** mediates **STAU2- and activity-dependent dendritic localization**. | Recent reviews use Calm3 as a canonical mechanistic example linking RNA structure recognition to STAU2-dependent localization. | Zhukova et al., *BioEssays* (2024) (pqac-00000002); Taylor & Nikolaou, *Front. Mol. Neurosci.* (2024) via gathered evidence summarized in (pqac-00000007) |
| Key mechanism: Staufen-mediated mRNA decay (SMD) | STAU2 participates in **SMD**, a pathway targeting mRNAs with **double-stranded RNA regions in their 3′ UTRs**. Recent evidence summarized in reviews indicates STAU2 can interact with **itself** and with **STAU1** and promote **UPF1 helicase** activity (but not ATPase activity) within SMD-related regulation. | Reviews emphasize that both **STAU1 and STAU2** are involved in SMD; recent figure-based summaries explicitly place STAU2 among SMD effectors acting on 3′-UTR dsRNA structures. | Cottrell et al., *Molecular Cell* (2024) (pqac-00000010, pqac-00000011); Zhukova et al., *BioEssays* (2024) (pqac-00000002); Quesada (2023) (pqac-00000003) |
| Major interaction partners | Supported partners/process-linked interactors include **STAU1**, **STAU2 self-association**, and **UPF1** in SMD-related regulation. A 2023 experimental study also identified interaction of **STAU2 N-terminus** with the **RTP1S N-terminus** in olfactory receptor trafficking assays; the olfactory receptor itself did **not** significantly interact with STAU2. | Interaction evidence is uneven: STAU1/UPF1 are mechanistically established in SMD-focused reviews; RTP1S comes from a recent proximity-labeling/NanoBiT study and suggests a context-specific noncanonical role. | Zhukova et al., *BioEssays* (2024) (pqac-00000002); Inoue et al., *IJMS* (2023) (pqac-00000006) |
| Quantitative findings | Recent review-level quantitative summaries report about **~1,200 STAU2-associated mRNA targets** identified by immunoprecipitation from rat brain and **356 neuronal mRNAs** with **3′-UTR binding by STAU2** in mouse brain. Another 2024 review notes STAU2 strongly binds retained introns in the **3′ UTRs of 28 mRNAs**. In olfactory receptor assays, co-expression of **STAU2** produced effects on Olfr544 surface expression **similar to HSPA6**, while HSPA6 co-expression increased surface expression by **~50–80%**. | These are the clearest quantitative values recovered in recent literature, though most are from rodent neuronal systems or review syntheses rather than direct human-cell measurements. | Zhukova et al., *BioEssays* (2024) (pqac-00000007); Taylor & Nikolaou, *Front. Mol. Neurosci.* (2024) via gathered evidence summarized in (pqac-00000007); Inoue et al., *IJMS* (2023) (pqac-00000006) |
| Biological contexts / applications | Current implementations are mainly **neuroscience-focused**: STAU2 is studied as a regulator of **neuronal development, migration, synaptic plasticity, and memory**, and as a factor influencing **astrocyte-to-neuron reprogramming**. A 2023 cell-based implementation implicated STAU2 in **RTP1S-dependent olfactory receptor trafficking**. | Human disease association evidence in Open Targets is currently weak/limited (low-score neurodevelopmental-disorder association with no direct evidence rows in the retrieved result), so disease claims should remain cautious. | Ciccopiedi (2024) (pqac-00000004, pqac-00000008); Inoue et al., *IJMS* (2023) (pqac-00000006); Open Targets search result (pqac-00000000) |


*Table: This table summarizes verified identity, molecular functions, localization, mechanisms, interaction partners, and quantitative findings for human STAU2 using only the gathered evidence. It is useful as a compact evidence map for building a longer research report on STAU2.*